Metabolic Diseases: all 1,002 studies

Page 10 of 11. Open to participants first (231), then studies with results posted, then the rest; newest registration first within each.

• Somatostatin Analogue Treatment of Acromegaly: Molecular AspectsCompletedNCT01723748Not applicable
• The Effect of Gluten on Gut Microbiome and Metabolic Health.CompletedNCT01719913Not applicable
• Prospective Cohort Study for Analyzing the Effect of Gastric Cancer Surgery to the Metabolic Syndrome and Insulin ResistanceWithdrawnNCT01714622
• Lean Seafood Intake and Postprandial MetabolismCompletedNCT01708681Not applicable
• The Effects of Amino Acid Supplement During Acute Inflammation.CompletedNCT01705782Not applicable
• Effects of Milk Protein Concentrate on Overall Health During Weight Loss in Overweight/Obese AdultsCompletedNCT01692860Not applicable
• Effect of High-calcium Intake on Appetite, Insulinemia and IncretinsCompletedNCT01682343Not applicable
• OPTIFIT-Optimal Fiber Trial for Diabetes PreventionCompletedNCT01681173Not applicable
• Effects of Vitamin D and Calcium Supplementation on Inflammatory Biomarkers and Adypocytokines in Diabetic PatientsStatus unknownNCT01662193Not applicable
• Fibrosis a New Pathological Actor in Adipose TissueCompletedNCT01655017Not applicable
• Moderated-fat Diet Complemented With Green Tea Reduces oxLDL and Fat Mass in Obese WomenCompletedNCT01628705Phase 4
• How Does Magnesium Status Influence Calcium Homeostasis?CompletedNCT01593501Phase 4
• Radius Loading in Primary HyperparathyroidismCompletedNCT01571843Not applicable
• Baseline Physiology Studies in Carriers of Gene Variant X Conferring Major Risk of CVD-prone Metabolic DisordersCompletedNCT01571609Not applicable
• Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell LymphomaCompletedNCT01569724Phase 4
• Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood TransplantationWithdrawnNCT01554254Phase 2
• Impairment in Glucose Homeostasis Among Obese Adolescents in High Risk Diabetes Prone Population - Jisr Az-Zarqa VillageStatus unknownNCT01535105
• An Observational Study of Patients With Lysosomal Acid Lipase Deficiency/Cholesteryl Ester Storage Disease PhenotypeCompletedNCT01528917
• The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM)CompletedNCT01527318Phase 4
• The Effect of Potassium Bicarbonate on Bone and Several Physiological Systems During ImmobilisationCompletedNCT01509456Not applicable
• Low Dose β-carotene Supplementation Diminishes Oxidative Stress in Type 2 Diabetics and Healthy IndividualsCompletedNCT01477112Not applicable
• Long Term Cardiovascular Complications in Men With Obstructive Sleep ApneaStatus unknownNCT01475682
• Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505CompletedNCT01474161Phase 1
• Effect of 6-week Strawberry Supplementation on Insulin Action (STR2)CompletedNCT01457612Not applicable
• Adaptation of Human Gut Microbiota to Energetic RestrictionCompletedNCT01454232Not applicable
• Endotoxin & Cytokines. Do Protein Loss and Metabolic Effects Depend on Central Nervous System (CNS) Activation of Stress Hormones or on Local Mechanisms in Muscle and Fat?CompletedNCT01452958Not applicable
• Study To Assess the Dietary Carbohydrate Content of Indian Diabetic PopulationCompletedNCT01450592
• Comparison of Postprandial Inflammation in Lean and Obese SubjectsCompletedNCT01446068Early Phase 1
• Characterisation of the Human Carboxylesterase 1 (CES1) Mutations in ThailandCompletedNCT01443806Phase 4
• Targeting the Gut Microbiome to Investigate the Pathways of Progression From Obesity to Metabolic Diseases in an At-risk Population.CompletedNCT01433120Not applicable
• Cirrhosis-DiabetesStatus unknownNCT01396954
• Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic DisordersTerminatedNCT01372228Phase 1/2
• A Single Dose Study In Japanese And Western Healthy Subjects To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-04991532CompletedNCT01369277Phase 1
• Adverse Events in Pharmaceutical Bioequivalence Study of Two Formulations of Metformine Hydrochloride 500 mgStatus unknownNCT01367054Not applicable
• Stearidonic Acid and Lipid MetabolismCompletedNCT01365078Not applicable
• Bisphosphonate Users Radiographic Characteristics of the Hip (BURCH) StudyCompletedNCT01360099
• Hepatocyte Transplantation for Liver Based Metabolic DisordersTerminatedNCT01345578Phase 1
• Trial of Two Central Venous Catheter (CVC) Flushing Schemes in Pediatric Hematology and Oncology PatientsTerminatedNCT01343680Phase 3
• A Telematic Program for Optimization of Metabolic Control in Diabetes Mellitus Type 1 (DM1) PatientsCompletedNCT01337141Not applicable
• Effects of IGF-I in HIV Metabolic DiseaseTerminatedNCT01329744Phase 1
• The Role of FGF23 and Asymmetric Dimethylarginine (ADMA) in Chronic Kidney DiseaseStatus unknownNCT01317186
• Omega 3 in Intervention Spinal Cord Injured PeopleCompletedNCT01311375Phase 2/3
• Unknown Glucose Metabolism Disorders In Patients With Coronary Artery DiseaseCompletedNCT01310556
• DEMOJUAN- DEMOnstration Area for Primary Prevention of Type 2 Diabetes, JUAN Mina and Barranquilla, ColombiaCompletedNCT01296100Not applicable
• Efficacy of Laflavon in Lowering Triglycerides and Raising High-Density Lipoprotein (HDL)Status unknownNCT01286909Phase 3
• Metabolic Assessment of Aging Men With Urinary LithiasisCompletedNCT01246531
• Multicentre Prospective Cohort Study of Patients With Chronic Alcoholic and/or Metabolic Liver DiseaseCompletedNCT01237574
• Effect of Taurine on Glycemic Control in Type I and Type II Diabetic PatientsStatus unknownNCT01226537Phase 1/2
• An Arrhythmia Risk Stratification and Genetic TrialCompletedNCT01209494
• Growing Up in Singapore Towards Healthy OutcomesActive, not recruitingNCT01174875
• The Role of Glucocorticoid Receptor SNPs in Receptor Function and Metabolic DiseaseCompletedNCT01143493
• The Effect of Proton Pump Inhibitors on Calcium and Bone MetabolismCompletedNCT01139645Not applicable
• Multiple Dose Study of PF-04991532 in Patients With Type 2 DiabetesCompletedNCT01129258Phase 1
• Study of Effects of Low Level Laser Therapy in the Physical Training and the Muscle Responses in Humans.CompletedNCT01113021Phase 1
• Improving Low Bone Mass With Vibration Therapy in Adolescent Idiopathic Scoliosis (AIS)CompletedNCT01108211Phase 3
• Single Dose Study of PF-04991532 in Healthy SubjectsCompletedNCT01102673Phase 1
• A Study of the Safety of R256918 in Obese PatientsCompletedNCT01041677Phase 2
• Fetal Umbilical Cord Blood (UCB) Transplant for Lysosomal Storage DiseasesWithdrawnNCT01003912Phase 1
• Impact of Adipose Tissue Repartition on the Time Course of Vascular Dysfunction - the NUMEVOX CohortStatus unknownNCT00997165
• To Investigate the Influence of Ethnicity in Metabolic Disease in Healthy, Overweight and Obese SubjectsStatus unknownNCT00988819
• Chung-ju Metabolic Disease Cohort (CMC) StudyStatus unknownNCT00707668
• Respiratory Health of Elite AthletesCompletedNCT00686491
• The Nutritional Status and Food Intake of Community Health AgentsCompletedNCT00682604
• Metabolic Derangements in Acute Heart Failure SyndromeTerminatedNCT00682175
• A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 DiabetesCompletedNCT00672386Phase 2
• Efficacy of Pamidronate in the Treatment of Bone Loss Associated With Liver TransplantCompletedNCT00657852Phase 4
• ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic DiseasesTerminatedNCT00654433Phase 3
• Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED)CompletedNCT00651963Phase 4
• A Study of the Safety and Effectiveness of JNJ-16269110 (R256918) in Overweight and Obese PatientsCompletedNCT00622765Phase 2
• Drug Utilization Prevalence in a Pediatric Care Medical CenterCompletedNCT00550706
• Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant RecipientsTerminatedNCT00504218
• One Year Glargine Treatment in CFRD Children and AdolescentsCompletedNCT00483769Phase 4
• Body Fat Distribution and Fat MetabolismCompletedNCT00475774Not applicable
• Accuracy and Safety of Real Time Continuous Glucose Monitoring Before, During and After SurgeryCompletedNCT00464529
• Socioeconomic Status, Psychosocial Factors, and CVD Risk in Mexican-American WomenCompletedNCT00387166
• Effect of an Anti-Oxidant Treatment on Resistin Serum Levels.A Randomized StudyTerminatedNCT00387114Phase 3
• Fenofibrate and Metformin Fixed Combination vs Metformin - FAME METFOCompletedNCT00362323Phase 3
• Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSITerminatedNCT00361868Phase 3
• Fenofibrate in Dyslipidemia and Metformin-Controlled DiabetesCompletedNCT00349128Phase 2/3
• Acceptability of a Fixed Combination of Fenofibrate and MetforminCompletedNCT00348725Phase 3
• The Early History of Universal Screening for Metabolic DisordersCompletedNCT00309400
• Pioglitazone in Impaired Glucose ToleranceWithdrawnNCT00306826Phase 4
• Rasburicase for HyperuricemiaCompletedNCT00290992Phase 2
• Study Evaluating Metabolic Syndrome in Subjects Undergoing Gastric Bypass Bariatric SyndromeTerminatedNCT00283374
• Acarbose and Secondary Prevention After Coronary StentingCompletedNCT00221156Phase 3
• Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy SubjectsCompletedNCT00192621Phase 4
• Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis PatientsCompletedNCT00157690Phase 4
• Education, Counseling, and Drug Therapy to Reduce Symptoms of Metabolic SyndromeCompletedNCT00129792Not applicable
• Chromium Picolinate for the Treatment of Metabolic SyndromeCompletedNCT00128154Not applicable
• The Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood GlucoseCompletedNCT00114855Not applicable
• Study of Lifestyle Modification in HIV LipodystrophyCompletedNCT00111358Not applicable
• Effects of Insulin Sensitizers in Subjects With Impaired Glucose ToleranceCompletedNCT00108615Phase 4
• The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) TrialCompletedNCT00095654Phase 3
• Electromagnetic Treatment For Bone Loss After Forearm FractureCompletedNCT00067834Phase 1/2
• Monoclonal Antibody Conditioning for Allogeneic Stem Cell Transplantation of Patients With Inherited Metabolic Storage DiseasesTerminatedNCT00056979Phase 1/2
• rhGAA in Patients With Infantile-onset Glycogen Storage Disease-II (Pompe Disease)CompletedNCT00053573Phase 1/2
• A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type IICompletedNCT00051935Phase 2
• Studies of Children With Metabolic and Other Genetic DisordersCompletedNCT00025870
• Use of Bone Biopsy to Better Understand the Causes of Decreased Bone Mineral Density in DepressionCompletedNCT00001916
• Study of Glycogen Storage Disease and Associated DisordersCompletedNCT00001342

← Metabolic Diseases overview